Treatment in Occupational Therapy With Significant Activities to Improve Quality of Life
Occupational Therapy Intervention for Alzheimer's Disease Patients. An International Comparison in Spain and Italy.
We followed a pretest-posttest non-equivalent control group experimental design study comparing two cohorts of patient with different types of dementia.
Approximately 250 patients will be screened to achieve 240 participants, divided in two cohorts (120 each), furthermore each cohorts was divided in other two groups (experimental group (60 each) and control group (60 each) the first one followed up by private centres in Spain endowed with Occupational Therapy and the second by public centres in the region of Modena.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The course of dementia goes through different stages and during the moderate and advanced stages cognitive decline and functional deterioration are frequently accompanied by the so-called behavioural and psychological symptoms of dementia (BPSD), that put severe stress on the persons with dementia (PwD), on their families and on the health system. Worldwide consensus guidelines recommend non-pharmacological approaches to be first line.
The occupational therapist studies human activity as a therapeutic resource to prevent and treat physical and/or psychosocial difficulties, in order to improve the person's quality of life.
Subjects were not randomly assigned to different treatment groups (control group and experimental group); instead, consecutive sampling was chosen by assigning subjects based on an odd-and-even-numbered technique (odd subjects were assigned to the control group and even subjects to the experimental group). Both groups presented the same pathological, cultural, and sexual characteristics, and belonged to the same age group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Burgos, Spain, 09003
- Olalla Saiz Vazquez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a diagnosis of primary dementia (DSM V)
- a MMSE score ≤ 24
- a NPI global score ≥ 32/144
- a treatment with significance activities in Occupational Therapy
- live in a nursing home
Exclusion Criteria:
presence of uncontrolled medical disease potentially contributing to the cognitive decline and BPSD
- concomitant psychiatric disorders or chronic alcoholism
- concomitant diseases severe enough to reduce life expectancy < 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: cards
participants received 2 days at week during 30 minutes
|
activities with purpose with people who are diagnosed of dementia 2 days at week during 30 minutes
|
|
Experimental: significance activities
participants received 2 days a week during 30 minutes
|
activities with purpose with people who are diagnosed of dementia 2 days at week during 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tinetti
Time Frame: 2 days
|
- The Tinetti test has been recommended and widely used in the elderly to assess mobility, balance and gait, and predict falls.
Different versions can be found.
A systematic literature search identified 37 publications on the Tinetti test and falls.
|
2 days
|
|
CDR
Time Frame: 2 days
|
- The Clinical Dementia Rating (CDR) has demonstrated high validity and reliability for this purpose, but it requires a considerable amount of data to be collected both from the patient and from an informant.
|
2 days
|
|
MMSE
Time Frame: 2 days
|
- The MMSE fulfilled its original goal of providing a brief screening test that quantitatively assesses the severity of cognitive impairment and documents cognitive changes occurring over time
|
2 days
|
|
NPI
Time Frame: 2 days
|
- The NPI-Q Spanish version offers the possibility to use a reliable and brief instrument that can be used as a screening in the evaluation of neuropsychiatric symptoms in dementia and associated caregiver distress
|
2 days
|
|
Barthel
Time Frame: 2 days
|
- Evidence suggests that (Barthel Index) BI is a valid measure of activities of daily living; sensitivity to change is limited at extremes of disability (floor and ceiling effects), and reliability of standard BI assessment is acceptable
|
2 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UBurgos2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.